Brain tumour clinical trial title

NCRN396: VE BASKET An open-label, phase II study of vemurafenib in patients with BRAF V600 mutation-positive cancers

Brain tumour type

Brain metastases, 

Website

public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=12071

Description:

An open-label, phase II study of vemurafenib in patients with BRAF V600 mutation-positive cancers. This is for patients with brain metastases.¬†Patients with brain metastasis are eligible if asymptomatic, off corticosteroid therapy and without evidence of disease progression in brain for ‚Č• 2 months.

Date added:

Open/Closed: Open

Trial ends: September 2015

Provider

NCRN Coordinating centre

Contact details

Dr Ian Chau :
UKCRN
15-19 Hyde Terrace
Leeds
LS2 9LT
E-mail: enquiries@ncrn.org.uk
Telephone:

Find on Google maps »